Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Pharm (128940 KS)
Watchlist
142
Analysis
Health Care
•
South Korea
Hanmi Pharm. Company Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hyundai Engineering & Construction
•
22 Apr 2025 00:12
Korea Value Up (3 Winners and 7 Losers Among KOSPI 200 Companies) In March and April 2025
In this insight, we provide the details of the 10 most recent companies in KOSPI 200 that have announced their Corporate Value Up plans (April and...
Douglas Kim
Follow
646 Views
Share
bullish
•
LG Chem
•
03 Apr 2025 01:04
A Pair Trade Between LG Chem (Common) And LG Chem (Preferred)
In this insight, we discuss a pair trade between LG Chem (051910 KS) (common) and LG Chem (051915 KS) (preferred). We recommend going long on LG...
Douglas Kim
Follow
725 Views
Share
bullish
•
Hanmi Pharm
•
10 Mar 2025 08:30
Hanmi Pharm (128940 KS): Corporate Value Enhancement Plan Targets W5 Trillion Revenue by 2033
Hanmi Pharm aims for robust revenue growth, targeting KRW2.3T in 2027 and KRW5T by 2033. Operating profit margin is expected to improve from 14.4%...
Tina Banerjee
Follow
370 Views
Share
bearish
•
Netmarble
•
05 Feb 2025 07:38
Korea: 11 Potential Index Deletions in February
There could be 11-12 index deletions in Korea later this month. Passive trackers will need to trade between US$42m-US$120m (4.2x-31x ADV) of the...
Brian Freitas
Follow
1k Views
Share
bearish
•
Samsung E&A
•
14 Jan 2025 10:20
Korea: Potential Relegations from K League 1
The list of potential deletions for Korea next month continues to increase as markets remain weak. The stocks have, on average, traded flat over...
Brian Freitas
Follow
1.2k Views
Share
First
Previous
13
14
15
16
17
18
19
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x